Endoscopic screening for gastrointestinal cancers

Precise estimates of the magnitude of benefits and harms of endoscopic screening for cancer are a prerequisite for informed decision making for or against participation in screening for individuals in the target population.

Photo: Colourbox

In the paper Do’s and don’ts in evaluation of endoscopic screening for gastrointestinal cancers published online first in the journal Endoscopy on Sept 21st, Michael Bretthauer and co-workers from the Clinical Effectiveness Research group outline the most common pitfalls in the evaluation of screening and offer recommendations for future studies.

Latest publications

Berg KCG et al., 2017. Multi-omics of 34 colorectal cancer cell lines – a resource for biomedical studies. Mol Cancer, 16(1): 116 Dienstmann R et al., 2017. Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study. Ann Oncol, 28(5): 1023-31 Eide PW et al., 2017. CMScaller: An R package for consensus molecular subtyping of colorectal cancer pre-clinical models. Sci Rep, 7(1): 16618 Øines M et al., 2017. Epidemiology and risk factors of colorectal polyps. Best Pract Res Clin Gastroenterol, 31(4): 419-24 Emilsson L et al., 2017. Colorectal cancer death after adenoma removal in Scandinavia. Scand J Gastroenterol, 52(12): 1377-84 All publications